ClinConnect ClinConnect Logo
Search / Trial NCT06975696

Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke

Launched by REGION SKANE · May 8, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Stroke Endovascular Thrombectomy Fusion Interventional Neuroradiology Procedure M Tici

ClinConnect Summary

This clinical trial is studying a new imaging technique called fusion imaging to improve the success of a treatment called endovascular thrombectomy (EVT) for patients experiencing an acute ischemic stroke, which is caused by a blockage in a large blood vessel in the brain. The goal is to see if using this advanced imaging can help doctors access the target blood vessel more easily, achieve faster blood flow restoration, and complete the procedure in a timely manner. Previous studies suggest that fusion imaging could lead to better outcomes for patients without making the procedure longer.

To participate in this trial, individuals need to be at least 18 years old and eligible for an EVT procedure. However, if someone has already been part of this study or does not have access to the necessary preoperative imaging, they would not be eligible. Participants can expect to receive standard care while also allowing researchers to evaluate how the new imaging technique affects their treatment outcomes. Overall, this study aims to enhance the effectiveness of stroke treatments, potentially leading to better recovery for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years.
  • 2. Eligible for an EVT procedure
  • Exclusion Criteria:
  • 1. Previous inclusion in this study
  • 2. No access to a preoperative CTA

About Region Skane

Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.

Locations

Helsinki, , Finland

Turku, , Finland

örebro, , Sweden

Patients applied

0 patients applied

Trial Officials

Ulrika Andersson, MSc

Study Director

Lund University

Johan Wasselius, MD, PhD

Principal Investigator

Skåne University Hospital and Lund University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported